An immunofluorescence platform is a diagnostic technology that uses fluorescent dyes to visualize the presence of specific biomolecules or microorganisms in a patient sample. The technology relies on specific binding between fluorescently labeled antibodies and their targets. When the target biomolecule or microorganism is present in a sample, it binds to the fluorescent antibody, creating a visible signal that can be detected using a microscope or specialized imaging system. Immunofluorescence platforms are used in a variety of diagnostic tests, including virus detection, autoimmune disease testing, and cancer diagnosis. The technology is highly sensitive, specific, and produces accurate results quickly, making it a valuable diagnostic tool in clinical settings.
An immunofluorescence platform is one type of POCT platform, works by using fluorescent dyes to visualize the presence of specific biomolecules or microorganisms in a patient sample. This is done by specific binding between fluorescently labeled antibodies and their targets, producing a visible signal that can be detected using a microscope or imaging system.
The advantages of using immunofluorescence platform tests include high sensitivity, specificity, and accuracy. The technology is highly versatile and can be used to diagnose a wide range of conditions. Immunofluorescence platform tests are also easy to perform, produce fast results, and can be automated for high throughput.
Email Us: 
TEL: 
2nd floor, No. 3, 8th Street, Qiantang Area, Hangzhou, Zhejiang, China 
中文
